Northwestern Mutual Wealth Management Co. Has $6.96 Million Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• Northwestern Mutual Wealth Management cut its Synopsys stake by 85.4% in the second quarter, retaining 15,615 shares valued at approximately $6.96 million. Institutional investors and hedge funds still own 85.47% of the company.
• Synopsys reported quarterly adjusted EPS of $3.91 versus the $3.67 consensus, while revenue rose 42.4% year over year to $2.48 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $561.28.
• Insiders sold approximately $40.7 million of stock during the quarter, including sales by the executive chair and CEO under pre-arranged Rule 10b5-1 plans. Shares trade at a high valuation, with a P/E above 70, leaving the stock sensitive to rising bond yields and broader semiconductor weakness.

Northwestern Mutual Wealth Management Co. trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 85.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,615 shares of the semiconductor company's stock after selling 91,219 shares during the quarter. Northwestern Mutual Wealth Management Co.'s holdings in Synopsys were worth $6,965,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in Synopsys during the 2nd quarter worth approximately $7,228,099,000. State Street Corp lifted its position in shares of Synopsys by 0.3% in the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company's stock worth $4,128,317,000 after purchasing an additional 28,532 shares during the period. Morgan Stanley boosted its stake in shares of Synopsys by 2.5% in the 4th quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company's stock valued at $2,148,491,000 after purchasing an additional 109,917 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Synopsys by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company's stock valued at $2,017,256,000 after purchasing an additional 54,329 shares during the last quarter. Finally, Van ECK Associates Corp increased its position in shares of Synopsys by 19.7% during the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock worth $1,542,175,000 after buying an additional 569,687 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Synopsys

In related news, insider Geus Aart De sold 24,641 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares in the company, valued at $50,518,611.92. This trade represents a 16.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 92,638 shares of company stock valued at $40,747,732. Company insiders own 0.56% of the company's stock.

Analyst Ratings Changes

SNPS has been the topic of several recent analyst reports. Zacks Research lowered shares of Synopsys from a "strong-buy" rating to a "hold" rating in a report on Friday, August 21st. Needham & Company LLC reiterated a "buy" rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, August 27th. Citigroup boosted their price objective on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Mizuho cut their target price on Synopsys from $600.00 to $550.00 and set an "outperform" rating on the stock in a research report on Thursday, August 27th. Finally, Weiss Ratings raised Synopsys from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, August 27th. Twelve research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $561.28.

Synopsys Trading Up 0.3%

NASDAQ:SNPS opened at $415.97 on Thursday. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $79.72 billion, a price-to-earnings ratio of 73.49, a PEG ratio of 2.27 and a beta of 1.23. The firm has a fifty day simple moving average of $414.25 and a two-hundred day simple moving average of $439.94.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business's quarterly revenue was up 42.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys, Inc. will post 11 EPS for the current fiscal year.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Wall Street analysts see approximately 25% potential upside based on the average price target. Synopsys maintains a “Moderate Buy” consensus, with several firms reiterating Buy ratings; Robert W. Baird upgraded the stock to Outperform and raised its target to $560. Wall Street Analysts See a 25.39% Upside in Synopsys
• Positive Sentiment: A recent analysis argues that the market may be underestimating Synopsys’ AI-related chip-design opportunity. The company’s latest revenue growth substantially exceeded that of a major electronic-design-automation rival, potentially supporting a valuation re-rating. The Market May Be Underestimating This AI Chip-Design Stock
• Positive Sentiment: Synopsys’ latest quarterly results provide fundamental support: adjusted EPS of $3.91 exceeded expectations of $3.67, revenue reached $2.48 billion versus a $2.44 billion estimate, and revenue increased 42.4% year over year.
• Neutral Sentiment: A look at Synopsys’ decade-long investment returns highlights its strong long-term performance, but the retrospective analysis is unlikely to materially affect near-term trading. Here's How Much You'd Have If You Invested $1000 in Synopsys a Decade Ago
• Negative Sentiment: Executive Chair Aart de Geus sold a combined 49,641 shares for roughly $21.4 million across transactions on August 31 and September 1. The sales reduced his holdings by about 17%; however, both transactions were made under a pre-arranged Rule 10b5-1 plan, which reduces their significance as a discretionary bearish signal. Synopsys SEC Insider Sale Filing
• Negative Sentiment: Synopsys is exposed to a broader semiconductor-sector pullback as rising global bond yields pressure high-multiple technology stocks. With a P/E ratio above 70 and the shares below their 200-day moving average, valuation and interest-rate sensitivity remain risks. Semiconductor Stocks Slide as Global Bond Selloff Lifts Yields

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source